Jean-François Pariseau - Venture Capital's team |

Jean-François Pariseau

Partner Montreal

Jean-François Pariseau is Partner in the Healthcare Fund. He joined BDC Venture Capital in 2001 and has over 20 years of investment and entrepreneurial experience in the healthcare sector.

Prior to joining BDC, Jean-François was an investment manager with CDP Capital Technology Ventures, a $2 billion global fund investing in healthcare, information technology and advanced technologies, where he was responsible for healthcare investments in Canada and the US. He has invested and managed more than $200 million in biopharmaceutical and medical device companies in North America. His experience includes transactions in private and in public companies, IPOs, M&A and fund investments. Prior to this, he was CEO of a consulting company specializing in regulatory affairs, and was VP, R&D for a pharmaceutical-product distribution company, both of which he founded.

Jean-François currently sits on the Board of Directors of AngioChem, Imagia Cybernetics, Clementia Pharmaceuticals (NASDAQ: CMTA) and Profound Medical (TSXV: PRN).

Jean-François holds a Bachelor of Science in Biotechnology from Université de Sherbrooke, a Master of Science in Biomedical Sciences from Université de Montréal, and an MBA from HEC Montréal.


T: 514-283-1401

Send a message

BDC Capital Team

Experienced. Knowledgeable. Capitalized. Connected.

At BDC Venture Capital, we are a team of dedicated, seasoned investment professionals, who bring our investee companies the benefit of decades of experience in the space. Each of our team members has been chosen for their in-depth knowledge and industry experience in sales, marketing, business development, production and R&D. It’s a team our investee companies and investment partners can trust and count on.

Contact our BDC Venture Capital team to learn more about investment opportunities for your company.